NCT00006254View on ClinicalTrials.gov

VNP20009 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2000

Study Completion Date

January 31, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

salmonella VNP20009

Trial Locations (2)

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Vion Pharmaceuticals

INDUSTRY

NCT00006254 - VNP20009 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter